Filter
5202
Filtered Results: 5202
Text search:
HIV
care,
support,
and
treatment
Featured
Recommendations
474
New Publications
1468
Language
Document type
No document type
3321
Studies & Reports
709
Guidelines
578
Manuals
207
Strategic & Response Plan
167
Training Material
79
Fact sheets
75
Situation Updates
32
Infographics
17
Resource Platforms
9
Brochures
6
App
1
Online Courses
1
Countries / Regions
India
252
Kenya
210
South Africa
185
Global
150
Ethiopia
130
Uganda
126
Malawi
123
Tanzania
122
Zambia
119
Nigeria
109
Nepal
101
Sierra Leone
100
Liberia
95
Namibia
92
Africa
82
Rwanda
81
Western and Central Europe
81
Bangladesh
72
Myanmar / Burma
71
Ghana
66
Lesotho
61
Ukraine
60
Zimbabwe
57
Latin America and the Carribbean
49
Eastern Europe
45
Mozambique
41
Cambodia
40
Philippines
38
Asia
38
Botswana
32
Indonesia
30
Senegal
28
Haiti
28
Russia
28
South–East Asia Region
27
South Sudan
27
Congo, Democratic Republic of
25
East and Southern Africa
24
Eswatini/ Swaziland
23
Burkina Faso
22
Guinea
21
Syria
20
Venezuela
16
West and Central Africa
14
Colombia
13
Germany
12
Vietnam
12
Pakistan
12
Cameroon
11
Albania
11
Middle East and North Africa
11
Eastern Europe and Central Asia
11
Georgia
11
Tajikistan
10
Brazil
10
North Macedonia
8
Papua New Guinea
8
Moldova
8
Sudan
8
Yemen
8
Central African Republic
8
Thailand
7
Benin
7
Afghanistan
7
Jordan
7
Southern Africa
7
Lebanon
7
Somalia
6
Laos
5
Mali
5
Timor Leste/ East Timor
4
China
4
Iran
4
Burundi
4
Armenia
4
Western Pacific Region
4
Sri Lanka
4
Iraq
4
Madagascar
4
Mexico
3
Turkey
3
Hungary
3
Portugal
3
Argentina
3
Romania
3
Poland
3
Angola
3
Bhutan
3
Switzerland
2
El Salvador
2
Serbia
2
Gambia
2
Chile
2
Estonia
2
Kyrgyzstan
2
Uzbekistan
2
Peru
2
Morocco
2
Qatar
2
Bulgaria
2
USA
2
Saudi Arabia
2
North America
2
Turkmenistan
2
Japan
2
Mauritius
2
United Kingdom
2
Spain
2
Bolivia
2
Greece
2
Palestine
2
North Korea
1
Togo
1
Kazakhstan
1
Canada
1
Singapore
1
Guinea-Bissau
1
Croatia
1
Paraguay
1
Gabon
1
Jamaica
1
Belgium
1
France
1
Tunisia
1
Norway
1
Azerbaijan
1
Belarus
1
Bosnia and Herzegovina
1
Côte d’Ivoire / Ivory Coast
1
Guyana
1
Djibouti
1
Egypt
1
Slovakia
1
Honduras
1
Chad
1
Libya
1
Authors & Publishers
Publication Years
Category
Countries
2202
Clinical Guidelines
422
Women & Child Health
328
Public Health
199
Key Resources
193
Capacity Building
144
Pharmacy & Technologies
37
Annual Report MEDBOX
3
Toolboxes
HIV
883
TB
484
COVID-19
245
Mental Health
236
Caregiver
152
AMR
131
Ebola & Marburg
95
Conflict
95
Disability
89
NTDs
86
Pharmacy
77
Refugee
68
Global Health Education
65
Rapid Response
60
Health Financing Toolbox
55
NCDs
50
Malaria
45
Natural Hazards
36
Planetary Health
35
Cholera
25
2.0 Rapid Response
20
Polio
20
Zika
10
Social Ethics
9
Specific Hazards
4
South Sudan
1
Typhoon
1
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t...
The United Nations Development Assistance Framework (UNDAF) 2018-2022 sets out the UN partnership aiming to support Nepal as it carves out its development agenda over the next five years. At the core of this new UNDAF are the SDGs, the Government of Nepal’s Fourteenth Plan, and international commi...
The State of the World’s Children 2013: Children with Disabilities examines the barriers – from inaccessible buildings to dismissive attitudes, from invisibility in official statistics to vicious discrimination – that deprive children with disabilities of their rights and keep them from partic...
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e220083chgsa, 2022
Two adjectives raise an issue for communicators working on Chagas disease (CD): “invisible and silent”. Two adjectives that can be ascribed to other neglected tropical diseases (NTD), but which are part of the essence of CD. Br...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
2nd edition. The interagency field handbook on malaria control was developed to set out effective malaria control responses in humanitarian emergencies, particularly during the acute phase when reliance on international humanitarian assistance is greatest. This second edition represents a thorough u...
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implemen...
Community led-monitoring is based on the principle that «Nothing that is done for us should
be done without us”. The combination of this principle with evidence shows that community-led
monitoring is an important driver of improved service delivery and health outcomes that needs to
be re-empha...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
The idea to the ANDEMIA online course manual is based on the challenge that resources for sending ANDEMIA students to a variety of face to face courses is limited not only due to financial but also time constraints. Online course provide a good basis for the students, Master, PhD and Post Docs to pr...
One health Response to AMR Containment.
In a significant move for the public health sector, Kerala has become the first state in India to launch an action plan to combat the growing cases of antimicrobial immunity, arising primarily from irrational use of medicines and excessive antibiotics used in...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
The purpose of this publication is to to provide a practical, stepwise approach to the implementation of the national action plans on AMR within the human health sector; and to provide a process and collation of existing WHO tools to prioritize, cost, implement, monitor and evaluate national action ...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
